Sep 19, 2022 7:00am EDT XORTX Completes Positive Pre-Phase 3 Meeting with the US Food and Drug Administration
Sep 01, 2022 7:00am EDT XORTX Sponsored Study Selected for Presentation at the American Society of Nephrology – Kidney Week 2022
Aug 22, 2022 7:00am EDT XORTX Announces Positive Topline Results from Part 2 Pharmacokinetics Bridging Study
Aug 04, 2022 7:00am EDT XORTX Announces Pre-Phase 3 Meeting Date with US Food and Drug Administration
Jul 13, 2022 7:00am EDT XORTX Announces Positive Topline Results from Pharmacokinetics Bridging Clinical Trial
Jul 07, 2022 7:00am EDT XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)